Navigating Change in the Healthcare Landscape Joseph Kishel PharmD, MBA and Pam Hawn, BS, PharmD CONTENT DESCRIPTION First, we will provide a high level overview of why health care changes were brought to the forefront of social, economic, and political issues. Then, we will discuss how health reform (specifically, the ACA (ACA=Affordable Care Act)) attempts to address these forces, because a broad understanding of the law first is helpful in order to have a deeper understanding of any one aspect. Of course this is a 2000-page document (with many more pages worth of interpretation), so we have identified key points to highlight. Once we discuss a few of the key initiatives, we’ll go over a “current events update” on topical issues in the news today (Medicaid expansion and health insurance exchanges), as they relate to insurance and coverage reform. Finally, we’ll take a closer look at the aspects that will most impact hospitals and providers of care– payment and delivery reform. Some of you may be aware of the value-driven payment initiatives are already underway, and we will take a closer look at this and provide a few examples of how institutions are responding. OBJECTIVES 1. Provide overview of why healthcare changes were brought to the forefront of social, economic, and political issues 2. Understand the rationale behind the ACA and the triple aim of the ACA 3. Discuss the reason for the move from fee for service delivery model to the ideal of Global payment CONTENT OUTLINE I. II. III. IV. Forces driving health care change a. State of US Healthcare b. Unsustainable growth c. High spending and poor performance Affordable Care Act overview a. The triple aim b. Targets of ACA c. Implementation State implemented update a. Medicaid expansion b. Health insurance exchanges Transforming payment and delivery models Spotlight on Critical Care 2014 Navigating Change in the Healthcare Landscape Joseph Kishel PharmD, MBA and Pam Hawn, BS, PharmD a. From fee for service to Global payment V. Summary & Questions SELF-ASSESSMENT QUESTIONS 1. Can you describe the “triple aim” of the affordable care act? 2. What two options do the states have for expanding access to healthcare under the affordable care act? 3. What are some of the impacts of value driven payment? REFERENCES Fineberg, HV. Shattuck Lecture. (2012). N Engl J Med, 366(11),1020-1027 Health at a Glance 2011: OECD Indicators. Why is health spending in the U.S. So High? http://www.oecd.org/unitedstates/49084355.pdf Squires, DA. (2011). The U.S. health system in perspective: a comparison of twelve industrialized nations. Issue Brief (Commonw Fund),16, 1-14. Berwick DM, et al. (2008).Health Aff (Millwood),27(3),759-769. McCarthy D, et al. (2010). The Commonwealth Fund. Spotlight On Critical Care 2014 Impact of an End of Life (EOL) Committee to Improve Communication between Nurses and Patients about EOL Decisions in the Intensive Care Unit (ICU) Marlena Fisher RN, BSN, CCRN; Martha “Peachy” Beene RN, BSN, CCRN CONTENT DESCRIPTION The presentation will focus on the role of an EOL committee in the ICU. We will discuss what prompted us to begin an EOL committee in the MICU. Once the committee was established our meetings focused on cultural awareness and how that impacts communication with patients and families. Other interventions included staff debriefings so that nurses had an outlet to discuss difficult patient deaths and scenarios. Lastly, we will discuss how we plan to proceed and expand the EOL committee at our institution. OBJECTIVES 1. Participants will be able to describe the role of an End of Life Committee in the ICU 2. Participants will be able to apply the tools to help improve nurse communication at the end of life. 3. Participants will be able to explain the tools to help decrease nurses’ moral distress in the ICU. CONTENT OUTLINE I. II. End of Life communication in the intensive care unit is flawed. a. Nursing satisfaction scores in the Medical ICU identified a lack of communication. b. With further analysis it was identified that this lack of communication was specific to end of life care. c. A quality improvement project was drafted: The End of Life Committee. d. Pre-Survey was distributed to MICU staff nurses to gather baseline data (n=32) i. 77% of nurses experience moral distress ii. 45% of nurses believed they provided futile care multiple times a month Aspects of the EOL Committee a. Monthly meetings i. Education including coping strategies for moral distress, cultural awareness, and EOL Care. ii. Debriefings on difficult patients b. Goals of Care Guidelines were created i. Initiate a family meeting and a palliative care consult if one of the criteria are met Spotlight on Critical Care 2014 Impact of an End of Life (EOL) Committee to Improve Communication between Nurses and Patients about EOL Decisions in the Intensive Care Unit (ICU) Marlena Fisher RN, BSN, CCRN; Martha “Peachy” Beene RN, BSN, CCRN III. IV. V. VI. ii. Guidelines are reviewed every Tuesday (“Goal of Care Tuesdays”) Assessment of EOL Committee a. Post-survey was distributed (n=26) i. 90% of nurses reported monthly staff debriefing sessions helped decrease moral distress ii. 66% of nurses perceived an increase in Goal of Care discussions iii. 47% of nurses perceived an increase in palliative care consults The EOL Committee was able to help improve communication in the ICU, increase resource utilization in the ICU, and decrease nurses’ moral distress. Future Goals of the EOL Committee a. Continue the monthly meetings and staff debriefing sessions b. Increase the membership to all ICUs (SICU and NSICU). c. Educate new graduate nurses on End-of-Life Nursing Education Consortium (ELNEC) information. d. Provide more support for families and patients at the end of life including comfort carts. e. Education efforts will be focused on teaching nurses effective, compassionate, and culturally sensitive end of life care. Conclusion a. As evidenced by our post-survey nurses’ perceived that the interventions implemented by the EOL committee helped decrease their moral distress and helped increase communication in the MICU. b. It is our goal to continue the EOL committee and expand our role throughout the ICUs. As well as expanding our scope of interventions to focus on education for new graduate nurses on providing family members more support when their loved one is dying. SELF-ASSESSMENT QUESTIONS 1. True or False: Research indicates that communication is ineffective in the ICU 2. True of False: One in five Americans die while in the ICU or soon thereafter Spotlight on Critical Care 2014 Impact of an End of Life (EOL) Committee to Improve Communication between Nurses and Patients about EOL Decisions in the Intensive Care Unit (ICU) Marlena Fisher RN, BSN, CCRN; Martha “Peachy” Beene RN, BSN, CCRN 3. True of False: An End of Life Committee may be a useful tool for nurses to learn better communication skills and how to care for patients at the end of life. REFERENCES Boyle, D., Miller, P., Forbes-Thompson, S. (2005). Communication and End-oflife-care in the intensive care unit: Patient, family, and clinician outcomes. Critical Care Nursing Quarterly 28, p.302-316. White, D. B., Cua, S. M., Walk, R., Pollice, L., Weissfeld, L., Hong, S., Landefeld, C. S., Arnold, R. M. (2012). Nurse-led intervention to improve surrogate decision making for patients with advanced critical illness. American Journal of Critical Care, 21(6), p. 396-409 Spotlight on Critical Care 2014 CARING FOR VENTRICULAR ASSIST DEVICE PATIENTS: NOT A QUESTION OF IF, BUT OF WHEN Tonya Elliott, RN, MSN, CCTC, CHFN CONTENT DESCRIPTION This presentation will cover content about the incidence and prevalence of heart failure (HF) as a platform for understanding how common this therapy is and will likely be in the future. A review of the Pathophysiology of HF will give participants a foundation to understand the rationale behind the therapies that are now accepted in the 2013 Heart Failure Guidelines. Indications for pump implant will give participants triggers for referring patients to advanced heart failure therapy programs. Through images and demo models that will be passed around the room, participants will be able to touch and see the components of the systems. Handling and seeing the components will give participants a sense of the commitment patients must make to this therapy. The metamorphosis of this technology from a large volume displacement pump to small continuous flow pumps changes the way patients are monitored and the kinds of complications they experience. The impact of continuous flow physiology will be reviewed by presenting the ways to monitor patients and pump function and a discussion of the common complications of this therapy. A description of the patient experience throughout the continuum of care will provide participants with information about the surgery, recovery, transition to home, and life in the community. The growing number of patients with continuous flow physiology is having an impact on the health care community. The model of care around this patient population is changing creating the need for hub/spoke programs and shared care practices. As VAD patients grow in number and length of support, they require ongoing care from every discipline. It’s not a question of if, but when, each of us will care of a VAD patient. OBJECTIVES 1. Describe the indications for implantation of a ventricular assist device 2. Describe the basic components and operation of the system 3. State 5 “Do and Don’ts” while caring for VAD patients CONTENT OUTLINE I. II. Introduction: a. Incidence and prevalence of HF b. Impact of an aging population VADs are a mainstay of treatment for advanced heart failure: a. Indications for implant Spotlight on Critical Care 2014 CARING FOR VENTRICULAR ASSIST DEVICE PATIENTS: NOT A QUESTION OF IF, BUT OF WHEN Tonya Elliott, RN, MSN, CCTC, CHFN III. IV. V. VI. VII. VIII. IX. b. Definition of DT vs. BTT Therapies for the treatment of HF Referral to implant center Evaluation process Implant hospitalization Transition of care Community preparation Managing an expanding patient population SELF-ASSESSMENT QUESTIONS 1. Describe the progression of heart failure from stage A to stage D 2. State the basic components of Ventricular Assist Device Systems and their function 3. Name 8 patient conditions that lead to poor pump performance REFERENCES Casida, J.M., Peters, R.M., & Magnan, M.A. (2009). Self-care demands of persons living with an implantable LVAD. Res Theory Nurs Pract., 23(4), 279-93. doi: 10.1891/1541-6577.23.4.2791 Feldman, D., Pamboukian, S.V., Teuteberg, J.J., Birks, E., Lietz, K., Moore, S.A.,…Rogers, J. (2013). The 2013 International Society for Heart and Lung Transplatation guidelines for mechanical circulatory support. Journal Heart Lung Transplant, 32(2), 157-187. Doi: http://dx.doi.org/10.1016/j.healun.2012.09.013 Khazanie, P., Hammill, B.G., Patel C.B., Eapen, Z.J., Peterson, E.D., Rogers, J.G.,…Hernandez, A.F. (2014). Trends in the use and outcomes of VADs among Medicare beneficiaries 2006-2011. JACC, 63(14), 1395-404. Doi: 10.1016/jacc.2013.12.020 Spotlight on Critical Care 2014 Management of Spontaneous Pneumothorax Mary Duggan MS, RN, CCRN, ACNP‐BC; Christy Schatz RN, MSN, FNP‐BC, CRNFA CONTENT DESCRIPTION This presentation will provide an overview of the pathophysiology of spontaneous pneumothorax as a disease of the pleura with evidence of pleural porosity and blebs. The presentation will provide a review of the importance of intrapleural pressures to maintain an expanded lung. The presentation will review clinical symptoms and diagnostic imaging. Presentation topics will cover management of pneumothorax including observation vs chest tube, including small bore vs large bore chest tubes, suction vs water seal, heimlick valve and management of persistent air leak. This presentation will put emphasis on prevention of recurrence of pneumothorax and provide an overview of surgical procedures and post-op management including video of intraoperative VATS procedures. OBJECTIVES 1. Participants will be able to describe the risk factors, pathophysiology, clinical presentation and differential diagnosis of spontaneous pneumothorax 2. Participants will be able to differentiate clinical management options with chest tube management 3. Participants will be able to identify the indications for and management of patients undergoing surgery for pneumothorax CONTENT OUTLINE I. II. Pathophysiology and risk factors of pneumothorax a. Disease of the pleura-primary vs secondary b. Review intrapleural pressures c. Risk factors-body type d. Clinical symptoms of pneumothorax e. Diagnostic imaging Medical management of pneumothorax a. Observation vs chest tube b. Small bore vs large bore chest tubes c. Suction vs water seal d. Indications for ambulatory heimlick valve e. Persistent air leak f. Recurrence management Spotlight on Critical Care 2014 Management of Spontaneous Pneumothorax Mary Duggan MS, RN, CCRN, ACNP‐BC; Christy Schatz RN, MSN, FNP‐BC, CRNFA III. Surgical procedures-curative treatment a. Blebectomy, parietal pleurectomy, pleurodesis b. VATS vs thoracotomy c. Post-op management SELF-ASSESSMENT QUESTIONS 1. What are the risk factors, pathophysiology, clinical presentation and differential diagnosis of spontaneous Pneumothorax? 2. What are the different clinical management options after chest tube placement? 3. What types of management strategies are used in persistent air leaks and failure to re-expand? REFERENCES Baumann, MH et al. Management of spontaneous pneumothorax: (2001). American College of Chest Physicians Delphi Consensus Statement. 119, p. 590-602. Henry, M et al. BTS guidelines for the management of spontaneous pneumothorax (2003). Thorax.58(2) p.39-52. MacDuff, A et al. Management of spontaneous pneumothorax. (2010). British Thoracic Society Pleural Disease Guidelines 65(2) p. 18-31 Miller, AC. (1993). Guidelines for the management of spontaneous pneumothorax. BMJ 307 p. 114-116. Spotlight on Critical Care 2014 High Risk Medications Rose Dunkle, RN, BSN, MSN, CCRN CONTENT DESCRIPTION Novice Nurses & nursing students in Critical Care can be easily overwhelmed when faced with the large and diverse amounts of high risk medications administered both IV push and via IV infusion. Common categories of high risk medications will be reviewed. Best practices for administration of high-risk medication will be reviewed. Review of complications of high-risk medications will be discussed. The session will also include questions and answers. OBJECTIVES 1. Discuss categories of High Risk Medications used in Critical Care 2. Discuss safety strategies & best practices when administering high risk medications 3. Nursing considerations with IV push versus IV drip high risk medications CONTENT OUTLINE I. II. III. Introduction-Overview of High Risk Medications a. Electrolyte Replacements b. Diuretics c. Sedation & Analgesia d. Vasoconstrictors & Vasodilators e. Inotropes Best Practices for Administration of High Risk Medications a. Know your resources for safe medication administration b. Review Generic as well as Brand Names c. Review safe medication ranges d. 2 RN double check & other best practices e. Escalation Complications of High Risk Medications a. Dose related b. Administration rate related c. Drug interactions SELF-ASSESSMENT QUESTIONS 1. Discuss 3 safety strategies/best practices when administering high risk medications 2. List 3 IV medications that are categorized as positive inotropes Spotlight on Critical Care 2014 High Risk Medications Rose Dunkle, RN, BSN, MSN, CCRN 3. Discuss the complication of administering furosemide (Lasix) too quickly. REFERENCES (2013). Nursing pharmacology made incredibly easy, 3rd edition. Wolters Kluwer/Lippincott, Williams & Wilkins. (2013). Pathophysiology made incredible easy. Wolters Kluwer/Lippincott, Williams & Wilkins. (2014). Retrieved from http://epocrates.com/ Baird, M. S., & Bethel, S. (2011). Manual of critical care nursing interventions and collaborative management, 6th edition. Elsevier. White, K., (2013). Fast facts for critical care. Kathy White Learning System. Spotlight on Critical Care 2014 10 OUT OF 10: CURRENT CHALLENGES AND STRATEGIES IN PAIN MANAGEMENT Brigit Hynes, RN, MSN & Robyn Smith, BSN, RN, CCRN CONTENT DESCRIPTION Today in the acute care setting, nursing staff are faced with many challenges to control their patient’s pain. With drug shortages, drug dependence, and patient expectations, pain management is getting more difficult to treat with “just opioids.” This can leave not only the patient dissatisfied with their pain relief, but also the nurse frustrated and concerned for the safety of the patient. This presentation will review several cutting edge modalities in pain management. One of these regimes is ketamine. Long known as an anesthetic, ketamine can now be used for analgesia without causing all the sedating and respiratory depressing effects that opioids cause. In fact, ketamine may be used in the acute care setting in and out of the ICU. Another cutting edge modality is with Authorized Agent Controlled Analgesia, where pain management can be administered to patients who are unable to medicate themselves. Different from PCA by proxy, AACA is specifically designed for pain management by a competent healthcare provider who is authorized to administer a pain regimen to a patient without the long term sedative effects of a continuous infusion. Great success has been made in pain management, even within the most challenging situations. As healthcare professionals, we must continue to explore other evidence based medications and administration routes, especially in our vulnerable patient populations. OBJECTIVES 1. Discuss the current evidence in support of using ketamine as an analgesic 2. Describe continuous ketamine infusions in the acute care setting for acute, chronic and acute-on-chronic pain management 3. Determine two differences between AACA and PCA by proxy CONTENT OUTLINE I. II. Current challenges in pain management in the acute care setting: a. Growing dependence on opioids in the outpatient population b. Drug shortages and the impact on the acute care setting c. Patient expectations in regards to pain control during hospital stay Thinking beyond opioids: a. Multimodal analgesia b. Regional anesthesia c. Continuous ketamine infusions Spotlight on Critical Care 2014 10 OUT OF 10: CURRENT CHALLENGES AND STRATEGIES IN PAIN MANAGEMENT Brigit Hynes, RN, MSN & Robyn Smith, BSN, RN, CCRN III. IV. d. Authorized Agent Controlled Analgesia (AACA) The role of ketamine in the intensive care unit patient: a. To decrease total opioid requirements b. To reduce adverse effects from opioids while receiving ketamine infusion continuously c. Management of side effects from ketamine d. Indications for ketamine administration in the ICU patient population e. Current evidence based research of ketamine as an analgesic, not just anesthetic The role of AACA in the Intensive Care Unit: a. AACA verses PCA by proxy b. AACA in the adult population c. Evidence in support of the AACA d. Education of healthcare provider SELF-ASSESSMENT QUESTIONS 1. True or False: Authorized Agent Controlled Analgesia (AACA) means that the patients power of attorney or surrogate decision maker may push the button to administer the patient a dose of pain medication. 2. True or False: When a patient is on a ketamine infusion for pain management, they should NOT receive any other analgesics. 3. When should a benzodiazepine be administered to a patient receiving a ketamine infusion? 4. What are two indications for using AACA? REFERENCES Cooney, M.F., Czarnecki, M., Dunwoody, C., Eksterowicz, N., Merkel, S., Oakes, L.,& Wuhrman, E. (2013). American Society for Pain Management Nursing position statement with clinical practice guidelines: authorized agent controlled analgesia. Pain Management Nursing, 14(3), 176-181. Doi: 10.1016/j.pmn.2013.07.003. Ely, E.W., Truman, B., Shintani, A., Thomason, J.W., Wheeler, A,P, Gordon, S.,…Bernard, G.R. (2003). Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). Journal of American Medical Association, 289(22), 2983-91. Doi:10.1001/jama.289.22.2983. Spotlight on Critical Care 2014 10 OUT OF 10: CURRENT CHALLENGES AND STRATEGIES IN PAIN MANAGEMENT Brigit Hynes, RN, MSN & Robyn Smith, BSN, RN, CCRN Himmelseher, S., & Durieux, M.E. (2005). Ketamine for perioperative pain management. Anesthesiology, 102(1), 211-220. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15618805 Infusion Nurses Society. (2011). Policies and procedures for infusing nursing, 4th ed. Institute for Safe Medication Practice (ISMP). (2013). Fatal PCA adverse events continue to happen…better patient monitoring is essential to prevent harm. ISMP. Retrieved from http://www.ismp.org/newsletters/acutecare/showarticle.aspx?id=50 The Joint Commission. (2012). Safe use of opioids in hospitals. The Joint Commission Sentinel Event Alert (49). Retrieved from http://www.jointcommission.org/assets/1/18/SEA_49_opioids_8_2_12_final.p df Pasero, C., McCaffery, M. (2011). Pain Assessment and Pharmacologic Management (313-322). St. Louis, Missouri: Mosby Elsevier. Pasero, C., McCaffery, M. (2005). Pain control: ketamine: low doses may provide relief for some painful conditions. American Journal of Nursing, 105(4), 60-64. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15791081 White, P.F. (2005). The changing role of non-opioid analgesic techniques in the management of postoperative pain. Anesthesia Analgesia, 101(5 Suppl), S5-22. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16334489 Spotlight on Critical Care 2014 Pulmonary Hypertension: The Nurse’s Role in Improving Outcomes George Ruiz, M.D. CONTENT DESCRIPTION Dr. Ruiz presents concepts using pictorial and descriptive devices that enable the learner to comprehend challenging pathophysiology and treatment modalities. The learner will be introduced to the presentation of and impact of pulmonary hypertension. The interplay between the pulmonary vasculature and the right heart will be explained conceptually with a focus on the pathological outcomes of abnormalities. Dr. Ruiz will review the basic workup for pulmonary hypertension, which will equip nurses to care for during this phase and educate patients about what to expect. Additionally the treatment options and associated patient education will be discussed. OBJECTIVES 1. Develop a deeper understanding of pulmonary hypertension: How it presents, why it matters and explore the interaction between pulmonary vasculature and the right heart; how their interactions determine outcomes. 2. Review the basic workup for a patient suspected of having pulmonary hypertension 3. Explore treatment options available for pulmonary hypertension CONTENT OUTLINE I. II. III. IV. Introduction: (5 minutes) a. New hope for patient with pulmonary hypertension b. The role of the Pulmonary Hypertension Center of Excellence Pathophysiology of Pulmonary Hypertension (15 minutes) a. How it presents b. Why it matters c. The interaction between the pulmonary vasculature and the right heart d. How their interaction between the pulmonary vasculature and right heart determine outcomes Basic workup for a patient suspected of having pulmonary hypertension (10 minutes) a. History taking b. Lab tests c. Diagnostic studies Treatment options available for pulmonary hypertension (15 minutes) a. Oral Medications Spotlight on Critical Care 2014 Pulmonary Hypertension: The Nurse’s Role in Improving Outcomes George Ruiz, M.D. V. i. Patient selection ii. Patient education b. Inhaled medications i. Patient selection ii. Patient education c. Infused medications i. Patient selection ii. Patient education Question and Answer (5 minutes) SELF-ASSESSMENT QUESTIONS 1. Which symptoms are commonly present when pulmonary hypertension patients initially present for medical care? 2. What is the interaction between the pulmonary vasculature and the right heart? What symptoms does abnormal pulmonary vasculature cause? 3. What patient selection criteria should be considered for the various medications used to treat pulmonary hypertension? What medications education should patients receive? REFERENCES McLaughlin, V. V., Archer, S. L., Badesch, D. B., Barst, R. J., Farber, H. W., Lindner, J. R.,...Varga, J. (2009). ACCF/AHA 2009 Expert consensus document on pulmonary hypertension. Journal of the American Association of Cardiology, 53(17), 1573-1619. Rogers, F. (2012). Helping patients understand the complex pulmonary hypertension workup. Advances in Pulmonary Hypertension, 11(2), 65-66. Stewart, T. (2010). Facilitating pulmonary arterial hypertension medication adherence: Patient-centered management. Advances in Pulmonary Hypertension, 8(4), . Retrieved from http://www.phaonlineuniv.org/Journal/Article.cfm?ItemNumber=786 Spotlight on Critical Care 2014 Introduction to Legal Issues in Hospital Setting Mollie Slater RN, BSN, Esq (Ohio only) CONTENT DESCRIPTION This presentation will not constitute legal advice. No attorney-client relationship shall be established. No real names or real cases will be used. The difference between criminal law and civil law is the intent of the outcome. The criminal law is meant to punish, while the civil law is meant to make a person whole. In the criminal law, individuals are found "guilty" and "not guilty." In civil law, individuals are found "liable" or "not liable". In the health care setting, negligence is the failure to meet the accepted standard of care which is the actual and proximate cause of an injury. First, there is a trial on liability only. Then, there is a separate trial or hearing on damages. Nurses are included in suits under an agency theory of liability. Employers are generally responsible for their employee's negligence as long as their employee was acting within the course and scope of their employment. Statutes of limitations are determined at the state level. Many companies offer nurses and other licensed health care professionals their own independent insurance policy, separate from anything that an employer may provide. These offer extra protection in case of suit. However, plaintiffs' attorneys seek out these policies as another means of recovering judgments. Each health care professional should make the determination on his/her own as to whether to purchase these supplemental policies. OBJECTIVES 1. Define and describe criminal law, civil law, medical negligence & statute of limitations 2. Describe the agency theory of liability & understand the pros and cons of individual liability insurance 3. Describe the characteristics of good nursing documentation CONTENT OUTLINE I. Introduction a. Two Cases i. Criminal vs. Civil; ii. What’s the difference? Spotlight on Critical Care 2014 Introduction to Legal Issues in Hospital Setting Mollie Slater RN, BSN, Esq (Ohio only) II. III. Main Point a. What is… i. Negligence ii. Standard of Care; how is it determined iii. Proximate cause vs. Actual cause iv. Burden of proof in civil and criminal law b. Damages i. Economic vs. Non-economic damages ii. Punitive damages iii. Proving damages – what evidence cane be used? c. Liability – how are nurses “named” in suits? i. Agency Theory of Liability ii. Course and scope of employment iii. What happens if you change hospitals; work as traveler or agency nurse? d. Purchasing supplemental insurance i. Pros and cons e. Statute of Limitations f. Elements of good documentation Conclusion SELF-ASSESSMENT QUESTIONS 1. Do you know the required elements in a medical negligence suit? 2. Do you know the difference between criminal and civil law? 3. Do you know what to do if you receive a nursing-related legal document? (i.e., subpoena, complaint, interrogatory) REFERENCES Bal, Sonny, B. (2009). An introduction to medical malpractice in the United States. Clinical Orthopaedics and Related Research, 467(2), 339-347. doi:10.1007/s11999-008-0636-2 Pegalis, Steven, E., & Bal, Sonny, B. (2012). Closed medical negligence claims can drive patient safety and reduce litigation. Clinical Orthopaedics and Related Research, 470(5), 1398-1404. doi: 10.1007/s11999-012-2308-5 Furrow, Barry, R., Greaney, Thomas, L., Johnson, Jost, Timothy, S., & Schwartz, Robert, L. (2010). Health law: Cases, materials, and problems. Eagan, MN: West. Spotlight on Critical Care 2014 Putting the Patient Picture Together: Using Critical Care Thinking at the Bedside Robin R. Jackson, MSN, RN‐BC, CCRN, CCNS & Rachel Smigelski‐Theiss, MSN, RN, ACCNS‐AG CONTENT DESCRIPTION Putting the Patient Picture Together: Critical thinking is an important tool in providing safe patient care. The concepts of critical thinking are developed over time with increasing experience and by asking questions related to the patient’s condition. Understanding how critical thinking develops and using case studies help to cultivate critical thinking skills. Part of critical thinking is knowing when and how to communicate patient information. Situation, Background, Assessment, and Recommendation (SBAR) provides a concise method of communication that provides key information to the physician. This talk will discuss concepts in critical thinking using case studies. Communication with the Licensed Independent Practitioner (LIP) will be covered using SBAR communication. OBJECTIVES 1. Explain how critical thinking is developed. 2. Identify situations where critical thinking is needed in patient care. 3. Identify the components of SBAR communication. CONTENT OUTLINE I. II. III. IV. Introduction: a. What is critical thinking? b. What is critical thinking NOT? Why is critical thinking so important to nurses? a. To manage complex dilemmas b. For empowerment: autonomous practice c. To exchange views and information d. Independent in mind or judgment; self-directed Pitfalls/barriers to critical thinking: a. Following an illogical process b. Personal bias c. Time factors Factors that enhance critical thinking: a. Being open minded b. Being self-confident Spotlight on Critical Care 2014 Putting the Patient Picture Together: Using Critical Care Thinking at the Bedside Robin R. Jackson, MSN, RN‐BC, CCRN, CCNS & Rachel Smigelski‐Theiss, MSN, RN, ACCNS‐AG V. VI. VII. VIII. IX. X. XI. XII. XIII. XIV. XV. c. Support system Key assumptions for critical thinking: a. It is rational b. It requires reflection c. It is an expansion of problem solving and the nursing process d. It involves both cognitive and affective skills The skills can the taught, learned and measured: a. The skills need to be practiced and reinforced b. It involves creative thinking c. It is both a process and an outcome Are you a critical thinker? Process of critical thinking: a. How do experts and novices make decisions Summary of critical thinking Physician communication: a. Follow the general guidelines to determine the need for calling the physician Nurse responsibility: a. Collect, organize and analyze all patient data b. Inform other nurses before making the call c. Identify yourself, unit, patient, purpose of call, and actual/potential problem d. Convey information in a clear and concise manner e. As appropriate, be prepared to answer questions and make appropriate recommendations (SBAR) Nurses are trained to be narrative and descriptive Physicians are trained to be problem solvers, “What do you want me to do?” or “Just give me the headlines” (SBAR). SBAR communication: a. Situation b. Background c. Assessment d. Recommendation Effective communication requires: a. Structured communication –SBAR b. Assertion/critical language- key words, the ability to speak up and stop the show c. Psychological safety- an environment of respect Spotlight on Critical Care 2014 Putting the Patient Picture Together: Using Critical Care Thinking at the Bedside Robin R. Jackson, MSN, RN‐BC, CCRN, CCNS & Rachel Smigelski‐Theiss, MSN, RN, ACCNS‐AG XVI. XVII. XVIII. d. Effective leadership- flat hierarchy, continuously inviting team members into the conversation SBAR in a nutshell: a. Situation: the punch line, give it in 5-10 seconds b. Background: a brief history that answers the question “how did we get here?” c. Assessment: data and findings d. Recommendation: answer the question “what do we need to do? And when?” SBAR examples Case studies SELF-ASSESSMENT QUESTIONS 1. Define critical thinking as it relates to nursing 2. Identify components of critical thinking 3. Identify strategies to develop critical thinking REFERENCES Alfaro-LeFevre, R. (2003). Improving your ability to think critically. Healthcare Traveler, 11(1), 72. Retrieved from http://search.proquest.com/docview/216620691?accountid=35812 Hughes, R (ed.). (2008). Patient Safety and Quality: An Evidenced-based Handbook for Nurses. Rockville, MD: Agency for Healthcare Research and Quality. Jenkins, S.D. (2011). Cross-cultural perspectives on critical thinking. Journal of Nursing Education, 50(5), 268-274. doi:http://dx.doi.org/10.3928/01484834-2011022802 Newton, S.E., & Moore, G. (2013). Critical thinking skills of basic baccalaureate and accelerated second degree nursing students. Nursing Education Perspectives, 34(3), 154158. Retrieved from http://search.proquest.com/docview/1370894743?accountid=35812 Zori, S., Kohn, N., Gallo, K., & Friedman, M. (2013). Critical thinking of registered nurses in a fellowship program. The Journal of Continuing Education in Nursing, 44(8), 374-380. doi: http://dx.doi.org/10.3928/00220124-20130603-03 Spotlight on Critical Care 2014 What’s A Nurse To Do, When There Is Nothing Left to Do? Palliative Care For Critically Ill Patients Sarah Bayne, MSN, FNP‐BC, ACHPN CONTENT DESCRIPTION Death is something that human beings cannot escape no matter how good medicine or technology has become. Clinicians can and should help families through this process to make it as good as it can be in the face of chronic and debilitating illnesses that are often symptomatic. The trajectory of death has changed over time and clinicians and educators have had to change how they handle this process. Nurses have a unique role in caring for these patients across all settings but specifically the inpatient setting. A basic understanding of the differences between palliative care and hospice is integral. Early identification of patients that may be appropriate for this type of care is necessary to facilitate patient and family education and symptomatic improvement in the disease process. The presence of palliative care in the intensive care unit setting has been shown to decrease cost, unnecessary procedures, medications and interventions while improving patient comfort and aligning the care with the patients’ goals. Nurses have a pivotal role when caring for critically ill patients approaching end of life. OBJECTIVES 1. Discuss the role of palliative care in the hospital setting 2. Identify barriers to caring for chronically critically ill patients 3. Describe the nurses’ role is in providing primary palliative care for critically ill patients in an inpatient setting (e.g., family education and symptom management) CONTENT OUTLINE I. II. III. Introduction of Palliative Care a. Case Study b. Describe the difference between inpatient palliative care and hospice c. Discuss the process of palliative consultation Identification of critically ill patients appropriate for palliative care a. Criteria for palliative care b. Discuss disease specific palliative care interventions Nursing Role a. Symptom management b. Patient and family education Spotlight on Critical Care 2014 What’s A Nurse To Do, When There Is Nothing Left to Do? Palliative Care For Critically Ill Patients Sarah Bayne, MSN, FNP‐BC, ACHPN IV. c. Family meeting and goals of care discussions Conclusions and Questions SELF-ASSESSMENT QUESTIONS 1. What is an example of an ICU patient appropriate for a palliative care consult? 2. What are some barriers to caring for chronically critically ill patients? 3. What is the role of the nurse in providing palliative care? REFERENCES Norton, S. A., Hogan, L. A., Holloway, R. G., Temkin-Greener, H., Buckley, M. J., Quill, T. E. (2007). Proactive palliative care in the medical intensive care unit: Effects on length of stay for selected high-risk patients. Critical Care Medicine, 35, p. 1530-1535 The IPAL Project: Improving palliative care in the ICU. (2014). Retrieved from http://www.capc.org/ipal/ipal-icu/. Walker, K. A., Mayo, R. L., Camire, L., Kearney, C. D., (2013). Effectiveness of integration of palliative medicine services into the intensive care unit. Journal of Palliative Medicine 16(10), 1237-1241. Spotlight on Critical Care 2014 Massive Transfusion in the Modern Age Lois L. Collins, RN, MSN, CEN CONTENT DESCRIPTION The role of massive transfusion protocols and rapid infusers are being ever more widely used for trauma resuscitation in the emergency department, operating room, and intensive care unit. This talk will review the initial management of shock in trauma patients, and then focus on blood product resuscitation utilizing the rapid infuser. OBJECTIVES 1. Identify and discuss hemorrhagic shock 2. Describe the four classes of hemorrhagic shock 3. Describe the use of massive transfusion protocols and delivery of massive transfusion utilizing a rapid transfusion system. CONTENT OUTLINE I. II. III. IV. V. Introduction a. Attention-getter video b. Review of objectives Overview of Shock a. Recognition of Shock b. Identification of causes/types of shock Hemorrhagic Shock a. Physical Exam b. Classes of Shock i. Confounding factors to classification c. Evaluation of Fluid Resuscitation and Organ Perfusion Massive Transfusion a. Facility Protocols b. Products Administered c. Rapid Transfusers Conclusion Spotlight on Critical Care 2014 Massive Transfusion in the Modern Age Lois L. Collins, RN, MSN, CEN SELF-ASSESSMENT QUESTIONS 1. What are the three components of the lethal triad of trauma? 2. How does the use of rapid transfusion technology impact patient outcomes? 3. What are the components of an effective massive transfusion protocol? REFERENCES Holcomb, J.B., Jenkins D., Rhee, P., Johannigman, J., Mahoney, P., Mehta, S., et al. (2007). Damage control resuscitation: Directly addressing the early coagulopathy of trauma. Journal of Trauma, 62, p. 307-310 Gonzalez, E. A., Holcomb, J. B., Miller, C. C., Kozar, R. A., Todd, S. R., et al. (2007). Fresh frozen plasma should be given earlier to patient's requiring massive transfusion. Journal of Trauma, 67, p. 112 Malone, D., L., Dunne, J., Tracy, J. K., Putnam, A. T., Scalea, T. N., Napolitano, L. M. (2003). Blood transfusion, Independent of shock severity, is associated with worse outcome in trauma. Journal of Trauma. 54, p. 898. Smith, M. J., Stiefel, M. F., Magge, S., Frangos, S., Bloom, S., Gracias, V. (2005). Packed red blood cell transfusion increases local cerebral oxygenation. Critical Care Medicine. 33, p. 1104. Spotlight on Critical Care 2014 Super Bugs-Antibiotic Resistant Organisms and Fighting Back Dorothy Belkoski RN, BSN, CCRN, CIC CONTENT DESCRIPTION Antibiotics can save lives and are depended on to treat severe infections, such as sepsis. But if not used properly-given to patients who do not need them, over prescribe or prescribe at the wrong dosage, allow organisms to develop resistance to the drugs that are used to treat serious infections. More organisms are developing resistance to antibiotics using different mechanisms and some organisms can transfer their resistance to other organisms. The supply and type of antibiotics is limited for use as these organisms become resistant, plug drug companies are not making as many new antibiotics. Some of the newer antibiotics are expensive and not available in all facilities. So as more resistance occurs, super bugs are taking over. This presentation will explain how organisms develop resistance, the most common, newest and most dangerous organisms, how to recognize resistance using sensitivity reports from the laboratory, how to prevent transmission through surveillance and isolation, and what can be done by employing antibiotic stewardship programs to stop deadly drug resistant organisms from developing and spreading. OBJECTIVES 1. Identify multi-drug resistant organisms (MDROs) and why they are resistant 2. Describe strategies to prevent transmission of MDROs 3. Describe strategies to prevent antibiotic resistance CONTENT OUTLINE I. II. III. Multi-drug Resistant organisms-definition a. MRSA b. VRE c. ESBL d. CRE Development of antibiotics and resistant organisms a. 1940-2011 Modes of organisms resistance a. Enzymatic inactivation b. Inherent (natural) resistance c. Acquired resistance d. Vertical gene transfer e. Horizontal gene transfer Spotlight on Critical Care 2014 Super Bugs-Antibiotic Resistant Organisms and Fighting Back Dorothy Belkoski RN, BSN, CCRN, CIC IV. V. Four Core Actions to Prevent Antibiotic Resistance a. Prevent infections, prevent the spread of resistance b. Tracking c. Improving antibiotic prescribing/stewardship d. Development of new drugs and diagnostic tests Next steps and strategies SELF-ASSESSMENT QUESTIONS 1. ESBL organisms make an enzyme that makes them resistant to which antibiotic? a. Tetracycline b. Cephalosporins c. Levaquin d. Vancomycin 2. True or False: Antimicrobial Stewardship is one of four core actions that prevent development of resistant organisms. 3. Which patients are the most prone of MDROs, especially CRE? a. Pediatric patients b. Patient's getting antibiotics for the first time c. ICU patients with multiple co-morbidities, hospitalizations and indwelling devices REFERENCES Antibiotic Resistance Threats in the United States. CDC. (2013). Retrieved from www.cdc.gov/features/antibioticresistancethreats/. Fact Sheet N*194. WHO Media Centere. (2014). Retrieved from www.who.int/mediacentre/factsheets/fs194/en/. Hanchett, Marilyn. A closer look-Antibiotic resistance and the microbiome. (2013). Prevention Strategist. Winter-6(4) p. 60-63 Paddock, Catharine. New generation of antibiotics may lie with small peptides. (2014). Retrieved from www.medicalnewstoday.com/articles/274561.php. Spotlight on Critical Care 2014 CASE STUDIES IN HEART FAILURE: 101 Kristina Hidalgo, CCRN, CCNS, ACNP CONTENT DESCRIPTION According to the CDC, there were one million heart failure admissions to the US hospitals in 2010. Students and novice nurses would benefit from a review of the evidence and guidelines for heart failure care with application via case studies. The presentation is geared toward new graduate RN’s with an emphasis on the physical examination, nursing interventions and pharmacological management of heart failure patients. Case studies are utilized in the presentation to emphasize application of the AHA/HFSA heart failure guidelines. The presentation concludes with a brief look into the future of advanced heart failure treatment so the new RN is aware of technological advances in the treatment of heart failure. OBJECTIVES 1. Describe the key points of the physical examination of the heart failure patient, including (but not limited to): jugular venous distention, edema, pulmonary and cardiac auscultation, and how they change in right, left and biventricular failure. 2. Identify the mechanism of action, major contraindications, and side effects of heart failure pharmacologic therapies including: diuretics, beta blockers, ace-inhibitors, angiotensin receptor blockers, anti-arrhythmics and anticoagulants. 3. Describe nursing interventions for the patient with heart failure, including: diet and medication education, fluid restriction, daily weights, and input/output documentation. CONTENT OUTLINE I. II. Introduction a. Define heart failure b. Etiology of heart failure c. Cost of heart failure d. Presentation objectives Illustration of the Importance of the Physical Examination a. Review of normal anatomy/physiology i. Right ventricle to the lungs, low pressure chamber ii. Left ventricle to the body, muscular high pressure chamber b. Left heart failure case i. Physical exam findings Spotlight on Critical Care 2014 CASE STUDIES IN HEART FAILURE: 101 Kristina Hidalgo, CCRN, CCNS, ACNP III. IV. V. ii. Warm/Cold Wet/Dry boxes c. Right heart failure case i. Physical exam findings Guidelines regarding pharmacologic management and nursing interventions a. Case study presentation b. Diuretics i. Mechanism of action ii. Contraindications iii. Side effects iv. Nursing interventions c. Beta Blockers i. Mechanism of action ii. Contraindications iii. Side effects iv. Nursing interventions d. Ace Inhibitors i. Mechanism of action ii. Contraindications iii. Side effects iv. Nursing interventions e. Antiarrythmics i. Mechanism of action ii. Contraindications iii. Side effects iv. Nursing interventions f. Anticoagulants i. Mechanism of action ii. Contraindications iii. Side effects iv. Nursing interventions The Future of Heart Failure Treatments a. Changes in ICD’s b. LVADs, BiVADs, TAH c. Transplantation d. CardioMEMS Questions SELF-ASSESSMENT QUESTIONS Spotlight on Critical Care 2014 CASE STUDIES IN HEART FAILURE: 101 Kristina Hidalgo, CCRN, CCNS, ACNP 1. What are signs of right heart failure vs. left heart failure? 2. What classes of drugs are recommended for heart failure patients and what contraindications/side effects are there to these drugs? 3. What nursing interventions are relevant to caring for the heart failure patient? REFERENCES Caccamo, M.A., & Eckman, P.M. (2011). Pharmacologic therapy for New York Heart Association class IV heart failure. Congestive Heart Failure, 17(5), 213-219. Doi: 10.1111/j.1751-7133.2011.00235.x McMurray, J.J., Adamopoulos, S., Anker, S.D., Aurichhio, A., Bohm, M., Dickstein, K.,…Zeiher, A. (2012). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. European Journal of Heart Failure, 14(8), 803-869. Doi: 10.1093/eurheartj/ehs104. Nohria, A., Mielniczuk, L.M., & Stevenson, L.W. (2005). Evaluation and monitoring of patients with acute heart failure syndromes. The American Journal of Cardiology, 96(6A), 32G-40G. doi: 10.1016/j.amjcard.2005.07.019. Yancy, C.W., Jessup, M., Bozkurt, B., Butler, J., Casey, D.E., Drazner, M.H.,…Wilkoff, B.L. (2013). 2013 ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Asscoiation task force on practice guidelines. Circulation, 128(16), e240-e327. Doi: 10.1161/CIR.0b013e31829e8776. Spotlight on Critical Care 2014 Stepping Forward by Stepping Back with Fecal Microbial Transplant Donna Stanczak, MS, RN, CCRN CONTENT DESCRIPTION Clostridium difficile is the leading cause of hospital-acquired diarrhea among adult patients. The identification of a new more virulent strain and the increased incidence in low risk populations have seen the incidence almost double in the last 10 years. It is well established that the infection begins with an alteration of the normal gut flora usually attributable to the use of antibiotics and more recently proton pump inhibitors. Surgical intervention has been associated with mortality rates of almost 50%. Despite treatment approximately 20 – 30% of patients experience at least 1 recurrence and the recurrence rates double with each successive infection. Fecal microbial transplant shows promise as a safe, cost-effective, permanent cure for this proliferating disease. This approach was first described in humans in 1958 and has long been used in animals with great success. Emerging literature has demonstrated that fecal microbial transplant has been gaining popularity and has documented cure rates of 90-94%. The information provided here will prepare critical care nurses to understand and participate in this emerging treatment modality. OBJECTIVES 1. Identify the incidence and complications associated with Clostridium difficile infection 2. Discuss the origins of fecal microbial transplant and mechanism of action 3. Discuss the use of fecal microbial transplant in the treatment of Clostridium difficile infection CONTENT OUTLINE I. Clostridium difficile a. Epidemiology b. Risk Factors c. Complications d. Prevention e. Current Treatment II. Fecal Microbial Transplant a. History Spotlight on Critical Care 2014 Stepping Forward by Stepping Back with Fecal Microbial Transplant Donna Stanczak, MS, RN, CCRN b. c. d. e. III. Pathophysiology Screening Procedure FDA Regulations Future Directions SELF-ASSESSMENT QUESTIONS 1. True or False: Fecal transplant can be traced back to 4th century China. 2. True of False: C. difficile is the leading cause of antibiotic related diarrhea. 3. True or False: Proton pump inhibitors have been associated with an increased risk of C. difficile infection. REFERENCES Floch, M. H. (2012). The power of poop: Probiotics and fecal microbial transplant. Journal of Clinical Gastroenterology, 46(8), 625-626. Johnson, D. A., & Oldfield, E.C. (2013). Reported side effects and complications of long-term proton pump inhibitor use. Clinics of Gastroenterology and Hepatology, 11(5), 458-464. Kelly, C. (2013). Fecal microbiota transplantation - an old therapy comes of age. New England Journal of Medicine, 368(5), 474-475. Khanna, S., & Pardi, D.S. (2012). Clostridium difficile infection: New insights into management. Mayo Clinic Proceedings, 87(11), 1106-1117. Rohlke, F., & Stollman, N. (2012). Feval microbiota transplantation in relapsing Clostridium difficile infection. Therapeutic Advances in Gastroenterology, 5(6), 403420. Van Nood, E., Speelman, P., Kuijper, E.J., & Keller, J.J. (2009). Struggling with recurrent Clostridium difficile infections: Is donor faeces the solution? Eurosurveillance, 14(34), 1-6. Spotlight on Critical Care 2014 Multisystem Effects of Traumatic Brain Injury Karen McQuillan RN, MS, CNS‐BC, CCRN, CNRC, FAAN CONTENT DESCRIPTION When severe injury occurs to the brain it often impacts numerous body systems. This session will review the pathologic effects that injury to the brain can have on non-neurologic systems and explain how these potential complications can then exacerbate secondary neurologic injury. Evidence based interventions to prevent and manage various systemic complications associated with traumatic brain injury will be described. OBJECTIVES 1. State the non-neurologic complications that may be associated with severe traumatic brain injury 2. Explain how non-neurologic complications can potentially exacerbate secondary brain injury 3. Formulate an evidence based plan of care aimed at preventing and treating potential non-neurologic complications associated with severe traumatic brain injury CONTENT OUTLINE I. II. III. IV. V. Introduction a. Primary vs. Secondary brain injury b. Incidence of non-neurologic organ dysfunction after severe brain injury c. Etiology of organ dysfunction after severe brain injury Respiratory complications a. Types and etiology b. Consequences to the injured brain c. Management of respiratory function in patient with severe brain injury Fluid and electrolyte imbalance a. Etiology b. Diabetes Insipidus c. SIADH d. Cerebral salt wasting Coagulopathy a. Etiology b. Consequences c. Management Myocardial dysfunction Spotlight on Critical Care 2014 Multisystem Effects of Traumatic Brain Injury Karen McQuillan RN, MS, CNS‐BC, CCRN, CNRC, FAAN VI. VII. a. Rhythm abnormalities b. Dysfunction etiologies c. Consequences of hemodynamic instability d. Management Others Conclusion SELF-ASSESSMENT QUESTIONS 1. Which organ system has the highest incidence of dysfunction after a severe traumatic brain injury? a. Respiratory b. Cardiac c. Skin d. Gastrointestinal 2. Hypoxia and hypercapnea can cause what type of brain injury? a. Primary brain injury b. Secondary brain injury c. Both primary and secondary brain injury 3. SIADH can be treated with? a. Fluid restriction b. Salt c. Vasopressin REFERENCES Hui X, Haider AH, Hashmi ZG, et al (2013). Increased risk for pneumonia among ventilated patients with traumatic brain injury:every day counts! J Surg Research. 184, 438-443 Ledwith MB, Bloom S, Maloney-Wilensky E, et al. (2010). Effect of body position on cerebral oxygenation and physiologic parameters in patients with acute neurological conditions. J Neurosc Nurs, 42(5),280-287. McQuillan KA, Thurman P. Traumatic Brain Injuries. In McQuillan KA, Flynn Makic MB, Whalen E, et al. (Eds.). Trauma Nursing: From Resuscitation Through Rehabilitation.(4th ed.). Philadelphia, PA: Elsevier, 2009. Inaba K, Menaker J, Branco BC, et al. (2013). Aprospective multicenter comparison of levetiracetam versus phenytoin for early posttraumtic seizure prophylaxis. J Trauma Acute Care Surg, 74(3), 766-773. Spotlight on Critical Care 2014 Multisystem Effects of Traumatic Brain Injury Karen McQuillan RN, MS, CNS‐BC, CCRN, CNRC, FAAN Maegele M. (2013).Coagulopathy after traumtic brain injury: incidence, pathogenesis nd treatment options. Transfusion, 53 (Supplement),28S-37S. Oddo M, Levine JM, Kumar M, et al. (2012). Anemia and brain oxygen after severe traumatic brain injury, J Intensive Care Med, 38, 1497-1504. Shahlaie K, Keachie K, Hutchins IM, et al. (2012). Risk factors for posttraumatic vasospasm. J Neurosurg, 115(3), 602-611. Vespa PM. (2013). Hormonal dysfunction in neurocritical patients. Curr Opin Crit Care, 19, 107-112. Spotlight on Critical Care 2014 Partners in Facilitating the Gift of Donation Matthew Niles, RN, MSN, MHA CONTENT DESCRIPTION Caring for a donor in the ICU is complex. Through this presentation you will learn why certain medication is given and certain tests are done during donor management to optimize and assist with evaluation of organ function. We will also detail the process of allocation of organs to transplant centers and their recipients. The nurse plays a pivotal role in the donation process: 1) timely referrals of imminent deaths; 2) assisting us with understanding of family dynamics and religion; 3) keeping us informed of family meetings; and 4) confirming to families that donation is standard end of life care for all patients. WRTC provides family care throughout the donation process. However, we also provide ongoing support to our donor families for two years through timed mailings of grief support brochures, in-house grief group sessions, recognition of the gift on an annual basis, our area-wide Donor Family Gathering in April and bringing together donor families and their recipients if desired. OBJECTIVES 1. List three organ and three tissues that may be transplanted. 2. Describe four of the clinical management goals necessary to maintain optimal organ function 3. Outline at least four components of the WRTC coordinator role CONTENT OUTLINE I. II. III. IV. It takes a team to facilitate organ and tissue transplants a. Eighteen people die each day waiting for transplants b. Medical and transplant team partner to improve outcomes Role of the WRTC Coordinator a. Education and consent b. Coordination of donor care Role of the Nurse a. Care of donor and family i. Discussion ii. Education b. Medical and Pharmacological support i. Managing donor care to meet criteria UNOs Spotlight on Critical Care 2014 Partners in Facilitating the Gift of Donation Matthew Niles, RN, MSN, MHA V. a. Criteria for wait list b. Donor registration Conclusion a. Organ and tissue donation saves lives i. Coordination between WRTC and medical team ii. Care of recipient and family iii. You can make a difference! SELF-ASSESSMENT QUESTIONS 1. What are the steps involved for the organ donation process? 2. Define brain death and how it relates to organ donation? 3. What vital roles do bedside ICU nurses play in successful organ donation? REFERENCES Gilligan, C., Sanson-Fisher, R., & Turon, H. (2012). The organ donation conundrum. Progress in Transplantation, 22(3), 312-316. Pickersgill, F., & Dean, E. (2011, June). Organ donation rate raised by dedicated nurse-led service. Emergency Nurse, 19(3), 3. The Organ Procurement and Transplant Network (www.optn.transplant.hrsa.gov). The quality standards subcommittee of the American Academy of Neurology. Practice parameters for determining brain death in adults [summary statement]. (1995). Neurology, 45, 1012-1014. The United Newtork for Organ Sharing (www.unos.org) Wijdicks, E. F., Fabinstein, A. A., Manno, E. M., & Atkinson, J. D. (2008). Pronouncing brain death: Contemporary practice and safety of the apnea test. Neurology, 71, 1240-1244. Wijdicks, E. F., Varelas, P. N., Gronseth, G. S., & Greer, D. M. (2010, June 8). Evidence-based guidelines update: Determining brain death in adults: A report of the quality standards of subcommittee of the American Academy of Neurology. Neurology, 74, 1911-1918. Spotlight on Critical Care 2014 Partners in Facilitating the Gift of Donation Matthew Niles, RN, MSN, MHA Wilkinson, K., & Peet, D. (2013, November 22). Organ Donation. InnovAit 2014, 7(109), 109-116. http://dx.doi.org/10.1177/1755738013506565 Spotlight on Critical Care 2014 Leading from the Bedside: Understanding How to Influence Your Colleagues and Overcome Communication Challenges Karen Mack, MS, MBA, ACNP‐BC, CHFN and Kelly McNeil‐Jones, RN, BSN, MBA, RCIS CONTENT DESCRIPTION From a needs assessment of GWAC’s student and first year nurses, concerns regarding “Physician Intimidation” and “Lateral Violence/Bullying” were identified. This session seeks to increase the learner’s knowledge base regarding organization culture, personal leadership styles, interpersonal negotiation, especially in collegial relationships with a “power-gradient”, and healthy work environment. Specific tools and case scenarios will provide learners with context the opportunity to trial skills discussed in the session such as “Code Purple”, “The Broken Record Technique”, “Validate and Verify”, “Speak up for Safety” and mastering own beliefs and stories. A Q&A period will allow learners to get feedback and information on challenging scenarios they have experienced personally through the use of question cards. OBJECTIVES 1. Discuss the incidence and impact of ineffective communication (lateral violence, intimidation, silence) 2. Understand the magnitude of importance that teamwork and clinical leadership plays in the efficient processing of the patients from admission through discharge 3. Discuss effective tools and techniques to facilitate communication and clinical leadership CONTENT OUTLINE I. II. III. Introduction a. What is a healthy work environment? b. Where is one found and how is one made? c. Throughput and Quality- The ultimate team sports Ineffective communication- The data about dysfunction a. Lateral violence b. Intimidation c. Silence The Clinical nurse’s toolbox for playing well in “The sandbox” a. Personal leadership style- Nurture and Nature Spotlight on Critical Care 2014 Leading from the Bedside: Understanding How to Influence Your Colleagues and Overcome Communication Challenges Karen Mack, MS, MBA, ACNP‐BC, CHFN and Kelly McNeil‐Jones, RN, BSN, MBA, RCIS b. Mastering your own stories c. Being a great colleague: Banking good will for future communication challenges d. Speak up for safety i. SBAR ii. Validate and verify iii. The broken record technique e. Tools the de-escalate including the code purple f. When to involve your leadership IV. V. Case studies Q&A via question cards SELF-ASSESSMENT QUESTIONS 1. What is a healthy work environment? 2. What are the costs of interpersonal communication challenges in the clinical setting? 3. What skills can I use when communication is challenging and the stakes are high? REFERENCES American Association of Critical Care Nurses. (2005). AACN Standards For Establishing And Sustaining Healthy Work Environments. Retrieved from http://www.aacn.org/wd/hwe/docs/hwestandards.pdf. Patterson, K., Grenny, J., McMillan, R., & Switzler, A. (2002). Crucial Conversations: Tools for Talking When Stakes Are High. New York, NY: McGrawHill. Rath, T. (2007). StrengthsFinder 2.0 (1st ed.). New York, NY: Gallup Press. Spotlight on Critical Care 2014 Focus the Flame: Attention on Excellence Karen McQuillan MS, RN, CNS‐BC, CCRN, CNRC, FAAN CONTENT DESCRIPTION The tumultuous health care environment, the rapid pace of change, and the everincreasing cost constraints conspire to challenge nurses’ abilities to provide high quality care and produce excellent outcomes. There is a connection between attention and excellence; cognitive science tells us we need three kinds of focus: inner, outer and other. We have an opportunity, some would say responsibility, to “create a healthcare system driven by the needs of patients and families where acute and critical care nurses make their optimal contributions”. In order to do this it is imperative we develop capacity in four domains: fearlessness, inquiry, resilience and engagement. OBJECTIVES 1. Identify the importance of developing our “attention” muscle 2. Define different strategies to “build” F.I.R.E. 3. Imagine the possibilities for fulfilling the mission and vision CONTENT OUTLINE I. II. III. IV. V. VI. Introduction a. President’s theme b. AACN mission statement: the meaning and the majesty The importance of the focus a. Cognitive science of focus b. Sources of focus: inner, outer, other The meaning of words a. F.I.R.E. and acronyms for the future b. Strategies for building Making sense of the chaos a. Predicting the future b. Leading, innovating, thriving c. Engaging the vision Conclusion: a. Review of President’s theme Questions Spotlight on Critical Care 2014 Focus the Flame: Attention on Excellence Karen McQuillan MS, RN, CNS‐BC, CCRN, CNRC, FAAN SELF-ASSESSMENT QUESTIONS 1. What is one way you will build your fearlessness, inquiry, resilience and engagement? 2. How will you ensure you fulfill AACN’s mission? 3. What are the sources of focus you’ll need? REFERENCES Goleman, D. 2013. Focus: the hidden driver of excellence. HarperCollins Publishers Inc.: New York. Robinson, K. 2009. The Element: how finding your passion changes everything. Penguin Group: New York. Wheatley, M. 2010. Perservance. Berkana Institute:www.berkana.org Spotlight On Critical Care 2014
© Copyright 2024